Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FA1W8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,363
Award facts
- Contract value 100% obligated
- $12,363.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,363.06 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 9, 2026, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen per milliliter formulation. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 12, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a critical pharmaceutical distributor for federal military healthcare systems and the Department of Defense Medical Supply Chain. The company maintains extensive federal contracting experience supplying a comprehensive portfolio of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Cosentyx, a specialty immunosuppressant medication used in treating autoimmune conditions, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for military treatment facilities and veteran healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FA1W8?
SPE2DR26FA1W8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FA1W8 worth?
The government has obligated $12,363 on SPE2DR26FA1W8.
Is contract SPE2DR26FA1W8 an order under another contract?
Yes. SPE2DR26FA1W8 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1W8 competed?
The extent of competition for SPE2DR26FA1W8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award